Interaction between arsenic exposure from drinking water and genetic polymorphisms on cardiovascular disease in Bangladesh: A prospective case-cohort study

Environmental Health Perspectives

Volumn 123, Issue 5, 2015, Pages 451-457

  Wu, Fen ^a   Jasmine, Farzana ^b   Kibriya, Muhammad G ^b   Liu, Mengling ^a   Cheng, Xin ^a   Parvez, Faruque ^c   Islam, Tariqul ^b,b   Ahmed, Alauddin ^b   Rakibuz Zaman, Muhammad ^b   Jiang, Jieying ^a   Roy, Shantanu ^b   Paul ‑ Brutus, Rachelle ^b   Slavkovich, Vesna ^b   Levy, Diane ^c   Vanderweele, Tyler J ^d   Pierce, Brandon L ^b   Graziano, Joseph H ^c   Ahsan, Habibul ^b   Chen, Yu ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c Department of Medicine   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; DRINKING WATER; ICAM1 PROTEIN, HUMAN; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; BANGLADESH; CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ARSENIC; BANGLADESH; CARDIOVASCULAR DISEASES; DRINKING WATER; ENVIRONMENTAL EXPOSURE; FEMALE; GENOTYPE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; STROKE; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84938373299     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1307883     Document Type: Article

References (68)

1. Agusa T, Iwata H, Fujihara J, Kunito T, Takeshita H, Minh TB, et al. 2010. Genetic polymorphisms in glutathione S-transferase (GST) superfamily and arsenic metabolism in residents of the Red River Delta, Vietnam. Toxicol Appl Pharmacol 242:352–362.
2. Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. 1980. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ 58:113–130.
3. Ahsan H, Chen Y, Kibriya MG, Slavkovich V, Parvez F, Jasmine F, et al. 2007. Arsenic metabolism, genetic susceptibility, and risk of premalignant skin lesions in Bangladesh. Cancer Epidemiol Biomarkers Prev 16:1270–1278.
4. Ahsan H, Chen Y, Parvez F, Argos M, Hussain AI, Momotaj H, et al. 2006. Health Effects of Arsenic Longitudinal Study (HEALS): description of a multidisciplinary epidemiologic investigation. J Expo Sci Environ Epidemiol 16:191–205.
5. Barlow WE. 1994. Robust variance estimation for the case-cohort design. Biometrics 50:1064–1072.
6. Barlow WE, Ichikawa L, Rosner D, Izumi S. 1999. Analysis of case-cohort designs. J Clin Epidemiol 52:1165–1172.
7. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265.
8. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 57:289–300.
9. Bermejo JL, Hemminki K. 2007. Gene–environment studies: any advantage over environmental studies? Carcinogenesis 28:1526–1532.
10. Bielinski SJ, Pankow JS, Li N, Hsu FC, Adar SD, Jenny NS, et al. 2008. ICAM1 and VCAM1 polymorphisms, coronary artery calcium, and circulating levels of soluble ICAM-1: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 201:339–344.
11. Bielinski SJ, Reiner AP, Nickerson D, Carlson C, Bailey KR, Thyagarajan B, et al. 2011. Polymorphisms in the ICAM1 gene predict circulating soluble intercellular adhesion molecule-1(sICAM-1). Atherosclerosis 216:390–394.
12. Blankenberg S, Rupprecht HJ, Bickel C, Peetz D, Hafner G, Tiret L, et al. 2001. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 104:1336–1342.
13. Breslow NE, Lumley T, Ballantyne CM, Chambless LE, Kulich M. 2009. Using the whole cohort in the analysis of case-cohort data. Am J Epidemiol 169:1398–1405.
14. Chen Y, Graziano JH, Parvez F, Liu M, Slavkovich V, Kalra T, et al. 2011a. Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study. BMJ 342:d2431; doi:10.1136/bmj.d2431.
15. Chen Y, Parvez F, Liu M, Pesola GR, Gamble MV, Slavkovich V, et al. 2011b. Association between arsenic exposure from drinking water and proteinuria: results from the Health Effects of Arsenic Longitudinal Study. Int J Epidemiol 40:828–835.
16. Chen Y, Santella RM, Kibriya MG, Wang Q, Kappil M, Verret WJ, et al. 2007. Association between arsenic exposure from drinking water and plasma levels of soluble cell adhesion molecules. Environ Health Perspect 115:1415–1420; doi:10.1289/ehp.10277.
17. Chen Y, Wu F, Graziano JH, Parvez F, Liu M, Paul RR, et al. 2013a. Arsenic exposure from drinking water, arsenic methylation capacity, and carotid intimamedia thickness in Bangladesh. Am J Epidemiol 178:372–381.
18. Chen Y, Wu F, Liu M, Parvez F, Slavkovich V, Eunus M, et al. 2013b. A prospective study of arsenic exposure, arsenic methylation capacity, and risk of cardiovascular disease in Bangladesh. Environ Health Perspect 121:832–838; doi:10.1289/ehp.1205797.
19. Chen Y, Wu F, Parvez F, Ahmed A, Eunus M, McClintock TR, et al. 2013c. Arsenic exposure from drinking water and QT-interval prolongation: results from the Health Effects of Arsenic Longitudinal Study. Environ Health Perspect 121:427–432; doi:10.1289/ehp.1205197.
20. Chiou HY, Huang WI, Su CL, Chang SF, Hsu YH, Chen CJ. 1997. Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke 28:1717–1723.
21. Engström K, Vahter M, Mlakar SJ, Concha G, Nermell B, Raqib R, et al. 2011. Polymorphisms in arsenic(+III oxidation state) methyltransferase (AS3MT) predict gene expression of AS3MT as well as arsenic metabolism. Environ Health Perspect 119:182–188; doi:10.1289/ehp.1002471.
22. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. 1995. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111–113.
23. Garcia-Closas M, Rothman N, Figueroa JD, Prokunina- Olsson L, Han SS, Baris D, et al. 2013. Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer. Cancer Res 73:2211–2220.
24. Gudnason V, Stansbie D, Scott J, Bowron A, Nicaud V, Humphries S. 1998. C677T (thermolabile alanine/ valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populations. EARS group. Atherosclerosis 136:347–354.
25. GVS (Genome Variation Server). 2013. GVS: Genome Variation Server 138. Available: http://gvs.gs.washington.edu/GVS138/ [accessed 24 December 2013].
26. HMP (International Hapmap Project). 2009. International Hapmap Project. Available: http://hapmap.ncbi.nlm.nih.gov/cgi-perl/gbrowse/hapmap27_B36/ [accessed 6 February 2009].
27. Hosmer DW, Lemeshow S. 1992. Confidence interval estimation of interaction. Epidemiology 3:452–456.
28. Hsieh YC, Hsieh FI, Lien LM, Chou YL, Chiou HY, Chen CJ. 2008. Risk of carotid atherosclerosis associated with genetic polymorphisms of apolipoprotein E and inflammatory genes among arsenic exposed residents in Taiwan. Toxicol Appl Pharmacol 227:1–7.
29. Hsieh YC, Lien LM, Chung WT, Hsieh FI, Hsieh PF, Wu MM, et al. 2011. Significantly increased risk of carotid atherosclerosis with arsenic exposure and polymorphisms in arsenic metabolism genes. Environ Res 111:804–810.
30. Hsueh YM, Lin P, Chen HW, Shiue HS, Chung CJ, Tsai CT, et al. 2005. Genetic polymorphisms of oxidative and antioxidant enzymes and arsenicrelated hypertension. J Toxicol Environ Health A 68:1471–1484.
31. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O’Donnell CJ, de Bakker PI. 2008. SNAP: a webbased tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24:2938–2939.
32. Karim MR, Rahman M, Islam K, Mamun AA, Hossain S, Hossain E, et al. 2013. Increases in oxidized lowdensity lipoprotein and other inflammatory and adhesion molecules with a concomitant decrease in high-density lipoprotein in the individuals exposed to arsenic in Bangladesh. Toxicol Sci 135:17–25.
33. Kelly PJ, Rosand J, Kistler JP, Shih VE, Silveira S, Plomaritoglou A, et al. 2002. Homocysteine, MTHFR 677C→T polymorphism, and risk of ischemic stroke: results of a meta-analysis. Neurology 59:529–536.
34. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG. 2002. MTHFR 677C→T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 288:2023–2031.
35. Kolsch H, Linnebank M, Lutjohann D, Jessen F, Wullner U, Harbrecht U, et al. 2004. Polymorphisms in glutathione S-transferase omega-1 and AD, vascular dementia, and stroke. Neurology 63:2255–2260.
36. Le Marchand L, Wilkens LR. 2008. Design considerations for genomic association studies: importance of gene-environment interactions. Cancer Epidemiol Biomarkers Prev 17:263–267.
37. Lee PH, Shatkay H. 2008. F-SNP: computationally predicted functional SNPs for disease association studies. Nucleic Acids Res 36(Database issue):D820–D824.
38. Lettre G, Lange C, Hirschhorn JN. 2007. Genetic model testing and statistical power in population-based association studies of quantitative traits. Genet Epidemiol 31:358–362.
39. Ma J, Möllsten A, Prázny M, Falhammar H, Brismar K, Dahlquist G, et al. 2006. Genetic influences of the intercellular adhesion molecule 1 (ICAM-1) gene polymorphisms in development of Type 1 diabetes and diabetic nephropathy. Diabet Med 23:1093–1099.
40. Medrano MA, Boix R, Pastor-Barriuso R, Palau M, Damián J, Ramis R, et al. 2010. Arsenic in public water supplies and cardiovascular mortality in Spain. Environ Res 110:448–454.
41. Meliker JR, Wahl RL, Cameron LL, Nriagu JO. 2007. Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: a standardized mortality ratio analysis. Environ Health 6:4; doi:10.1186/1476-069X-6-4.
42. Moon K, Guallar E, Navas-Acien A. 2012. Arsenic exposure and cardiovascular disease: an updated systematic review. Curr Atheroscler Rep 14:542–555.
43. Moon KA, Guallar E, Umans JG, Devereux RB, Best LG, Francesconi KA, et al. 2013. Association between exposure to low to moderate arsenic levels and incident cardiovascular disease. A prospective cohort study. Ann Intern Med 159:649–659.
44. Olshan AF, Li R, Pankow JS, Bray M, Tyroler HA, Chambless LE, et al. 2003. Risk of atherosclerosis: interaction of smoking and glutathione S-transferase genes. Epidemiology 14:321–327.
45. Pezzini A, Del Zotto E, Archetti S, Negrini R, Bani P, Albertini A, et al. 2002. Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke. Stroke 33:664–669.
46. Pierce BL, Kibriya MG, Tong L, Jasmine F, Argos M, Roy S, et al. 2012. Genome-wide association study identifies chromosome 10q24.32 variants associated with arsenic metabolism and toxicity phenotypes in Bangladesh. PLoS Genet 8:e1002522; doi:10.1371/journal.pgen.1002522.
47. Porter KE, Basu A, Hubbard AE, Bates MN, Kalman D, Rey O, et al. 2010. Association of genetic variation in cystathionine-β-synthase and arsenic metabolism. Environ Res 110:580–587.
48. R Core Team. 2011. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing. Available: http://www.R-project.org [accessed 8 July 2011].
49. Ragvin A, Moro E, Fredman D, Navratilova P, Drivenes Ø, Engström PG, et al. 2010. Long-range gene regulation links genomic type 2 diabetes and obesity risk regions to HHEX, SOX4, and IRX3. Proc Natl Acad Sci USA 107:775–780.
50. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. 1998. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 351:88–92.
51. Roest M, van der Schouw YT, Grobbee DE, Tempelman MJ, de Groot PG, Sixma JJ, et al. 2001. Methylenetetrahydrofolate reductase 677 C/T genotype and cardiovascular disease mortality in postmenopausal women. Am J Epidemiol 153:673–679.
52. Rothman KJ, Greenland S, Walker AM. 1980. Concepts of interaction. Am J Epidemiol 112:467–470.
53. Slot C. 1965. Plasma creatinine determination. A new and specific Jaffe reaction method. Scand J Clin Lab Invest 17:381–387.
54. SNAP (SNP Annotation and Proxy Search). 2008. SNAP: SNP Annotation and Proxy Search, Version 2.2. Available: http://www.broadinstitute.org/mpg/snap/ldsearch.php [accessed 14 October 2013].
55. Stampfer MJ, Allen J. 1998. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 351:88–92.
56. Steinmaus C, Moore LE, Shipp M, Kalman D, Rey OA, Biggs ML, et al. 2007. Genetic polymorphisms in MTHFR 677 and 1298, GSTM1 and T1, and metabolism of arsenic. J Toxicol Environ Health A 70:159–170.
57. VanderWeele TJ, Tchetgen Tchetgen EJ. 2014. Attributing effects to interactions. Epidemiology 25:711–722.
58. Wang GS, Cooper TA. 2007. Splicing in disease: disruption of the splicing code and the decoding machinery. Nat Rev Genet 8:749–761.
59. Wang XL, Greco M, Sim AS, Duarte N, Wang J, Wilcken DE. 2002. Glutathione S-transferase mu1 deficiency, cigarette smoking and coronary artery disease. J Cardiovasc Risk 9:25–31.
60. Wang YH, Wu MM, Hong CT, Lien LM, Hsieh YC, Tseng HP, et al. 2007. Effects of arsenic exposure and genetic polymorphisms of p53, glutathione S-transferase M1, T1, and P1 on the risk of carotid atherosclerosis in Taiwan. Atherosclerosis 192:305–312.
61. Wu F, Jasmine F, Kibriya MG, Liu M, Wójcik O, Parvez F, et al. 2012. Association between arsenic exposure from drinking water and plasma levels of cardiovascular markers. Am J Epidemiol 175:1252–1261.
62. Wu F, Molinaro P, Chen Y. 2014. Arsenic exposure and subclinical endpoints of cardiovascular disease. Curr Environ Health Rep 1:148–162.
63. Wu IC, Zhao Y, Zhai R, Liu CY, Chen F, Ter-Minassian M, et al. 2011. Interactions between genetic polymorphisms in the apoptotic pathway and environmental factors on esophageal adenocarcinoma risk. Carcinogenesis 32:502–506.
64. Wu MM, Chiou HY, Lee TC, Chen CL, Hsu LI, Wang YH, et al. 2010. GT-repeat polymorphism in the heme oxygenase-1 gene promoter and the risk of carotid atherosclerosis related to arsenic exposure. J Biomed Sci 17:70; doi:10.1186/1423-0127-17-70.
65. Wu MM, Kuo TL, Hwang YH, Chen CJ. 1989. Doseresponse relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol 130:1123–1132.
66. Yang M, Fu Z, Zhang Q, Xin Y, Chen Y, Tian Y. 2014. Association between the polymorphisms in intercellular adhesion molecule-1 and the risk of coronary atherosclerosis: a case-controlled study. PLoS One 9:e109658; doi:10.1371/journal.pone.0109658.
67. Yu L, Kalla K, Guthrie E, Vidrine A, Klimecki WT. 2003. Genetic variation in genes associated with arsenic metabolism: glutathione S-transferase omega 1-1 and purine nucleoside phosphorylase polymorphisms in European and indigenous Americans. Environ Health Perspect 111:1421–1427.
68. Zondervan KT, Cardon LR. 2004. The complex interplay among factors that influence allelic association. Nat Rev Genet 5:89–100.